Circular Code Biology
About:
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Website: https://www.circodebio.cn
Top Investors: Cowin Capital, Johnson & Johnson Innovation – JJDC, Kaitai Capital, Kunlun Capital, Yifeng Capital
Description:
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Total Funding Amount:
$20M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-06-01
Contact Email:
info(AT)circodebio.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-08-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai